Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Charles River Laboratories International, Inc. Common Stock (NY:CRL)

172.15 +3.18 (+1.88%)
Streaming Delayed Price Updated: 11:55 AM EST, Nov 11, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 313,911
Open 169.70
Bid (Size) 171.87 (100)
Ask (Size) 172.29 (100)
Prev. Close 168.97
Today's Range 167.60 - 172.16
52wk Range 91.86 - 222.10
Shares Outstanding 50,396,622
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
3 Healthcare Stocks We Approach with Caution
From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. Despite the rosy long-term prospects, short-term headwinds such as COVID... 
Via StockStory
Topics Stocks
Corporate Earnings Fuel Market Gains, But Mixed Results Hint at Underlying Volatility
Recent third-quarter (Q3) 2025 corporate earnings have painted a complex yet largely positive picture for North American equity markets. While robust performances from key sectors, particularly... 
Via MarketMinute
Topics Artificial Intelligence Earnings Economy

Performance

YTD
-5.7%
-5.7%
1 Month
+0.9%
+0.9%
3 Month
+15.6%
+15.6%
6 Month
+20.3%
+20.3%
1 Year
-22.0%
-22.0%

More News

Read More
Earnings Scheduled For November 5, 2025
Via Benzinga
This Charles River Laboratories Analyst Turns Bullish; Here Are Top 5 Upgrades For Thursday
Via Benzinga
Robinhood To Rally More Than 20%? Here Are 10 Top Analyst Forecasts For Thursday
Via Benzinga
CRL Q3 Deep Dive: Portfolio Streamlining and End Market Stabilization Shape Outlook
Via StockStory
Charles River (CRL) Q3 2025 Earnings Transcript
Via The Motley Fool
Charles River Beat Expectations But Why Is The Stock Falling?
Via Benzinga
Exploring the top movers within the S&P500 index during today's session.
Via Chartmill
Why Charles River Laboratories (CRL) Shares Are Getting Obliterated Today
Via StockStory
Topics Artificial Intelligence
Wednesday's session: gap up and gap down stock in the S&P500 index
Via Chartmill
Charles River Laboratories (NYSE:CRL) Tops Q3 Earnings Estimates Despite Flat Revenue
Via Chartmill
Topics Earnings
Charles River Laboratories’s (NYSE:CRL) Q3: Beats On Revenue
Via StockStory
Charles River Laboratories Provides Update on Strategic Review
From Charles River Laboratories International, Inc.
Via Business Wire
Charles River Laboratories Announces Third-Quarter 2025 Results
From Charles River Laboratories International, Inc.
Via Business Wire
What To Expect From Charles River Laboratories’s (CRL) Q3 Earnings
Via StockStory
Topics Artificial Intelligence
Charles River Laboratories Investigation Initiated By Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Charles River Laboratories International, Inc. - CRL
From Kahn Swick & Foti, LLC
Via Business Wire
Halper Sadeh LLC Encourages Charles River Laboratories International, Inc. Shareholders to Contact the Firm to Discuss Their Rights
From Halper Sadeh LLC
Via Business Wire
Charles River and the Francis Crick Institute Combine Expertise in Antibody-Drug Conjugate Development
From Charles River Laboratories International, Inc.
Via Business Wire
Charles River and X-Chem Announce Strategic Collaboration to Enhance Hit Identification Capabilities
From Charles River Laboratories International, Inc.
Via Business Wire
Discover which S&P500 stocks are making waves on Thursday.
Via Chartmill
Charles River Announces Scientific Advisory Board to Drive Alternative Method Innovation and Adoption
From Charles River Laboratories International, Inc.
Via Business Wire
Charles River Laboratories Schedules Third-Quarter 2025 Earnings Release and Conference Call
From Charles River Laboratories International, Inc.
Via Business Wire
3 Reasons to Avoid CRL and 1 Stock to Buy Instead
Via StockStory
Winners And Losers Of Q2: Charles River Laboratories (NYSE:CRL) Vs The Rest Of The Drug Development Inputs & Services Stocks
Via StockStory

Frequently Asked Questions

Is Charles River Laboratories International, Inc. Common Stock publicly traded?
Yes, Charles River Laboratories International, Inc. Common Stock is publicly traded.
What exchange does Charles River Laboratories International, Inc. Common Stock trade on?
Charles River Laboratories International, Inc. Common Stock trades on the New York Stock Exchange
What is the ticker symbol for Charles River Laboratories International, Inc. Common Stock?
The ticker symbol for Charles River Laboratories International, Inc. Common Stock is CRL on the New York Stock Exchange
What is the current price of Charles River Laboratories International, Inc. Common Stock?
The current price of Charles River Laboratories International, Inc. Common Stock is 172.15
When was Charles River Laboratories International, Inc. Common Stock last traded?
The last trade of Charles River Laboratories International, Inc. Common Stock was at 11/11/25 11:55 AM ET
What is the market capitalization of Charles River Laboratories International, Inc. Common Stock?
The market capitalization of Charles River Laboratories International, Inc. Common Stock is 8.68B
How many shares of Charles River Laboratories International, Inc. Common Stock are outstanding?
Charles River Laboratories International, Inc. Common Stock has 9B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.